You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

Returns | 1W : 2.5% , 1M : 2.4%,1Y : 83.6%
BOM : 531633     NSE : LINCOLN    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Aug 03,2021
Price(EOD): Rs. 355.15
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
LINCOLN PHARMACEUTICALS 2.5% 2.4% 83.6%
SUN PHARMACEUTICAL INDUSTRIES 15.6% 16.8% 51.9%
DR REDDYS LABORATORIES -0.2% -15.3% 4.1%
DIVIS LABORATORIES 2.4% 10.8% 92.4%
CIPLA 4.2% -5.3% 34.4%
BIOCON 2.1% -4.4% -3.3%
AUROBINDO PHARMA 0.2% -7.7% 11.9%
LUPIN 3.6% -1.4% 26.3%
TORRENT PHARMACEUTICALS 0.6% 5.2% 26.2%


FUNDAMENTAL ANALYSIS OF LINCOLN PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Mar2021, Y: Mar2020
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]
Show Me the Stocks with Fundamentals better than LINCOLN PHARMACEUTICALS Plus/Pro


VALUATION OF LINCOLN PHARMACEUTICALS

 
Valuation Score
[As on : Aug 03,2021 ]

Ratio Standalone
P/E
P/B
P/S
14.33
P/E Calculated based on EPS of 24.78
[ Mar2020 - Standalone Results ]

2.33
P/B Calculated based on Book Value of 152.25
[ Mar2020 - Standalone Results ]

1.72
P/S Calculated based on Revenues of 413.056 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than LINCOLN PHARMACEUTICALS Plus/Pro


FAIR VALUE OF LINCOLN PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
34%
21%
38%

SHARE PRICE MOMENTUM OF LINCOLN PHARMACEUTICALS

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.02
0.13
0.26
0.14
0.02
0.12
0.27
0.14
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Jun2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-30.89%
-24.59%
-18.55%
-11.36%
3.03%
83.84%
29.95%
28.36%
QtrlyTrend
0
Latest Qtr: Mar2021

LINCOLN PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 3.6% 2% 48.8%
S&P BSE SMALL CAP 2.9% 6.1% 109.6%
S&P BSE ALLCAP 2.7% 3.4% 54.8%
S&P BSE MIDSMALLCAP 2.6% 5.1% 90.2%
No NSE index found

FAQ [Frequently Asked Questions]


Is LINCOLN PHARMACEUTICALS good for long term investment?

As on 03-Aug-2021, the Fundamentals of LINCOLN PHARMACEUTICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of LINCOLN PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is LINCOLN PHARMACEUTICALS UnderValued or OverValued?

As on 03-Aug-2021, LINCOLN PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of LINCOLN PHARMACEUTICALS ?

As on 03-Aug-2021, the Intrinsic Value of LINCOLN PHARMACEUTICALS is Rs. 265.46 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 265.46
Fair Value [Median EV / Sales Model] : Rs. 294.23
Fair Value [Median Price / Sales Model] : Rs. 256.45
Median Fair Value of LINCOLN PHARMACEUTICALS : Rs. 265.46

Is LINCOLN PHARMACEUTICALS trading at a Premium or Discount?

As on 03-Aug-2021, LINCOLN PHARMACEUTICALS is trading at a Premium of 34% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of LINCOLN PHARMACEUTICALS ?

Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of AUROBINDO PHARMA LTD
Quarterly Results of LUPIN LTD
Quarterly Results of TORRENT PHARMACEUTICALS LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of ABBOTT INDIA LTD

What are the Frequent Comparisons with LINCOLN PHARMACEUTICALS ?

Compare Analytics
LINCOLN PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
LINCOLN PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
LINCOLN PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
LINCOLN PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
LINCOLN PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
LINCOLN PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
LINCOLN PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
LINCOLN PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
LINCOLN PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of LUPIN LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of ABBOTT INDIA LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z